O'Donnell M - Search Results

1

Apixaban in patients with atrial fibrillation.

Connolly SJ, Eikelboom J, Joyner C, Diener HC, Hart R, Golitsyn S, Flaker G, Avezum A, Hohnloser SH, Diaz R, Talajic M, Zhu J, Pais P, Budaj A, Parkhomenko A, Jansky P, Commerford P, Tan RS, Sim KH, Lewis BS, Van Mieghem W, Lip GY, Kim JH, Lanas-Zanetti F, Gonzalez-Hermosillo A, Dans AL, Munawar M, O'Donnell M, Lawrence J, Lewis G, Afzal R, Yusuf S; AVERROES Steering Committee and Investigators. Connolly SJ, et al. N Engl J Med. 2011 Mar 3;364(9):806-17. doi: 10.1056/NEJMoa1007432. Epub 2011 Feb 10. N Engl J Med. 2011. PMID: 21309657 Free article. Clinical Trial.

2

Novel antithrombotic therapies for the prevention of stroke in patients with atrial fibrillation.

O'Donnell M, Weitz JI. O'Donnell M, et al. Am J Manag Care. 2004 Apr;10(3 Suppl):S72-82. Am J Manag Care. 2004. PMID: 15152749 Free article. Review.

3

ESPRIT trial.

O'Donnell M, Eikelboom JW. O'Donnell M, et al. Lancet. 2006 Aug 5;368(9534):447; author reply 449. doi: 10.1016/S0140-6736(06)69144-7. Lancet. 2006. PMID: 16890824 No abstract available.

4

Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study.

O'Donnell M, Oczkowski W, Fang J, Kearon C, Silva J, Bradley C, Guyatt G, Gould L, D'Uva C, Kapral M, Silver F; Investigators of the Registry of the Canadian Stroke Network. O'Donnell M, et al. Lancet Neurol. 2006 Sep;5(9):749-54. doi: 10.1016/S1474-4422(06)70536-1. Lancet Neurol. 2006. PMID: 16914403

5

Pexelizumab does not "complement" percutaneous coronary intervention in patients with ST-elevation myocardial infarction.

Eikelboom JW, O'Donnell M. Eikelboom JW, et al. JAMA. 2007 Jan 3;297(1):91-2. doi: 10.1001/jama.297.1.91. JAMA. 2007. PMID: 17200480 No abstract available.

6

Challenges of establishing new antithrombotic therapies in atrial fibrillation.

Connolly SJ, Eikelboom J, O'Donnell M, Pogue J, Yusuf S. Connolly SJ, et al. Circulation. 2007 Jul 24;116(4):449-55. doi: 10.1161/CIRCULATIONAHA.107.695163. Circulation. 2007. PMID: 17646595 Review. No abstract available.

7

Beyond unfractionated heparin and warfarin: current and future advances.

Hirsh J, O'Donnell M, Eikelboom JW. Hirsh J, et al. Circulation. 2007 Jul 31;116(5):552-60. doi: 10.1161/CIRCULATIONAHA.106.685974. Circulation. 2007. PMID: 17664384 Review. No abstract available.

8

Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factors.

Cook D, Douketis J, Meade M, Guyatt G, Zytaruk N, Granton J, Skrobik Y, Albert M, Fowler R, Hebert P, Pagliarello G, Friedrich J, Freitag A, Karachi T, Rabbat C, Heels-Ansdell D, Geerts W, Crowther M; Canadian Critical Care Trials Group. Cook D, et al. Crit Care. 2008;12(2):R32. doi: 10.1186/cc6810. Epub 2008 Mar 3. Crit Care. 2008. PMID: 18315876 Free PMC article.

9

Using aspirin to prevent cognitive decline.

Eikelboom JW, O'Donnell M. Eikelboom JW, et al. BMJ. 2008 Sep 1;337:a958. doi: 10.1136/bmj.a958. BMJ. 2008. PMID: 18762478 No abstract available.

10

Tackling the global burden of stroke: the need for large-scale international studies.

O'Donnell M, Yusuf S. O'Donnell M, et al. Lancet Neurol. 2009 Apr;8(4):306-7. doi: 10.1016/S1474-4422(09)70024-9. Epub 2009 Feb 21. Lancet Neurol. 2009. PMID: 19233731 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,125 results

Search Page

Filters